OpenVSafe by OpenVAERS
Search V-safe

966-12355-23169

4 vaccinations 27 coded responses 52 check-ins 25 free-text entries 0 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
801 / CO
Registered
2021-02-08
Relationship
Self
Race
Asian
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-02-08
    Registered in v-safe
  2. 2021-02-15
    Dose 1 — Pfizer-BioNTech
  3. 2021-02-15
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-02-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-02-17
    Survey response — days 1–6 daily, dose 1
    MedDRA: Depression — Feeling: Good · Site: Pain · Fatigue or tiredness
    Free text: Depression
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-02-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Itching · Fatigue or tiredness
    Adult check-in
  7. 2021-02-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  9. 2021-02-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  10. 2021-02-22
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-03-01
    Survey response — day 14, dose 1
    MedDRA: Fatigue, Menstrual disorder — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Delayed period by about 8 days. Fatigue - impacted strenuous activity.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-03-08
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-03-11
    Dose 2 — Pfizer-BioNTech
  14. 2021-03-11
    Survey response — day 0, dose 2
    MedDRA: Dizziness — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-03-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Insomnia — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Insomnia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-03-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Rash, not including the immediate area around the injection site
    Adult check-in
  17. 2021-03-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Itching · Chills, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Adult check-in
  18. 2021-03-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Chills, Fatigue or tiredness, Nausea
    Adult check-in
  19. 2021-03-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  20. 2021-03-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  21. 2021-03-18
    Health check-in — day 7, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  22. 2021-03-25
    Survey response — day 14, dose 2
    MedDRA: Intermenstrual bleeding — Feeling: Good
    Free text: Spotting and possible early period
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-04-01
    Survey response — day 21, dose 2
    MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Headache
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-04-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-15
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-04-22
    Survey response — day 42, dose 2
    MedDRA: Chills, Diarrhoea, Vomiting — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: Vomiting and diarrhea, with chills, no fever. Most likely food poisoning
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-06-10
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-09-09
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  29. 2021-10-01
    Dose 3 — Pfizer-BioNTech
  30. 2021-10-01
    Survey response — day 0, dose 3
    MedDRA: Paraesthesia — Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness, Nausea
    Free text: Tingling in fingers
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-10-02
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Neuralgia, Paraesthesia — Feeling: Poor · Site: Pain, Swelling · Fever · Headache · Be unable to do your normal daily activities
    Free text: Painful lymph nodes, tingling and nerve pain in arm with injection
    MedDRA releases: 2024-11 · check-in free text available
  32. 2021-10-03
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy, Pain, Self-medication — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Lymph node in armpit swelled to golf ball size after last check-in, severe pain treated with switching 500mg naproxen/12hrs and 500mg/6 hrs and applying ice pack to reduce swelling, pain ranging from 4/10 to 8/10
    MedDRA releases: 2024-11 · check-in free text available
  33. 2021-10-04
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling, Itching · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Lymph node still swollen and painful, treated with 500mg naproxen and ice pack
    MedDRA releases: 2024-11 · check-in free text available
  34. 2021-10-05
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Swelling, Itching · Fatigue or tiredness
    Free text: Lymph node still swollen and tender to touch, pain less than previous days, no longer need pain medication to manage
    MedDRA releases: 2024-11 · check-in free text available
  35. 2021-10-06
    Survey response — days 1–6 daily, dose 3
    MedDRA: Breast pain, Lymph node pain — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Breast/lymph node soreness present but mild
    MedDRA releases: 2024-11 · check-in free text available
  36. 2021-10-07
    Survey response — days 1–6 daily, dose 3
    MedDRA: Breast pain, Lymph node pain — Feeling: Good · Site: Itching · Fatigue or tiredness, Nausea, Diarrhea
    Free text: Breast/lymph node pain is mild and does not interfere with ability to go to work or complete everyday activities
    MedDRA releases: 2024-11 · check-in free text available
  37. 2021-10-08
    Survey response — day 7, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Headache, Fatigue or tiredness, Diarrhea
    Free text: Lymph node swelling has improved, pain is mild and does not interfere with work or activities
    MedDRA releases: 2024-11 · check-in free text available
  38. 2021-10-15
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-10-31
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  40. 2021-11-07
    Survey response — day 35, dose 3
    MedDRA: Cough, SARS-CoV-2 test negative — Feeling: Good
    Free text: Coughing a lot, negative COVID tests
    MedDRA releases: 2024-11 · check-in free text available
  41. 2021-11-12
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  42. 2021-12-31
    Survey response — 3 months, dose 3
    MedDRA: Migraine, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Increase in migraine frequency from 1-2/year to 1-2/month
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-10-01
    Survey response — 12 months, dose 3
    MedDRA: Migraine — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: More frequent migraines
    MedDRA releases: 2024-11 · check-in free text available
  44. 2022-11-03
    Dose 4 — Pfizer-BioNTech
    Co-administered: Flu
  45. 2022-11-04
    Health check-in — days 1–6 daily, dose 4
    Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  46. 2022-11-05
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  47. 2022-11-06
    Survey response — days 1–6 daily, dose 4
    MedDRA: Bacterial infection, Sinusitis — Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Bacterial sinus infection being treated with antibiotics
    MedDRA releases: 2024-11 · check-in free text available
  48. 2022-11-07
    Survey response — days 1–6 daily, dose 4
    MedDRA: Sinusitis — Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Being treated for a sinus infection with doxycycline
    MedDRA releases: 2024-11 · check-in free text available
  49. 2022-11-08
    Survey response — days 1–6 daily, dose 4
    MedDRA: SARS-CoV-2 test positive — Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Tested positive for covid
    MedDRA releases: 2024-11 · check-in free text available
  50. 2022-11-09
    Survey response — days 1–6 daily, dose 4
    MedDRA: COVID-19, SARS-CoV-2 test positive — Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Still recovering from Covid - PCR test confirmed
    MedDRA releases: 2024-11 · check-in free text available
  51. 2022-11-10
    Survey response — day 7, dose 4
    MedDRA: Cough, Dyspnoea — Feeling: Poor · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Covid symptoms, trouble breathing, coughing
    MedDRA releases: 2024-11 · check-in free text available
  52. 2022-11-17
    Health check-in — day 14, dose 4
    Feeling: Fair
    Adult check-in
  53. 2022-11-25
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  54. 2022-12-01
    Survey response — day 28, dose 4
    MedDRA: COVID-19, Pain — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Body aches with no fever - had Covid after vaccination
    MedDRA releases: 2024-11 · check-in free text available
  55. 2022-12-16
    Survey response — day 42, dose 4
    MedDRA: COVID-19, Influenza — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Influenza A and covid resurgence
    MedDRA releases: 2024-11 · check-in free text available
  56. 2023-02-02
    Survey response — 3 months, dose 4
    MedDRA: Hypersensitivity, Palpitations, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities
    MedDRA releases: 2024-11
  57. 2023-05-04
    Survey response — 6 months, dose 4
    MedDRA: Breast tenderness, Lymphadenopathy — Feeling: Fair
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-02-15Pfizer-BioNTech
22021-03-11Pfizer-BioNTech
32021-10-01Pfizer-BioNTech No
42022-11-03Pfizer-BioNTech Flu

Free text

Release 4 — days 1–6 daily, dose 1

2021-02-17

Systemic reaction (other): Depression

Release 4 — day 14, dose 1

2021-03-01

Symptoms: Delayed period by about 8 days. Fatigue - impacted strenuous activity.

Release 5 — day 0, dose 2

2021-03-11

Systemic reaction (other): Dizziness

Release 5 — days 1–6 daily, dose 2

2021-03-12

Systemic reaction (other): Insomnia

Release 6 — day 14, dose 2

2021-03-25

Symptoms: Spotting and possible early period

Release 6 — day 21, dose 2

2021-04-01

Symptoms: Headache

Release 7 — day 42, dose 2

2021-04-22

Symptoms: Vomiting and diarrhea, with chills, no fever. Most likely food poisoning

Release 9 — day 0, dose 3

2021-10-01

Systemic reaction (other): Tingling in fingers

Release 9 — days 1–6 daily, dose 3

2021-10-02

Systemic reaction (other): Painful lymph nodes, tingling and nerve pain in arm with injection

2021-10-03

Systemic reaction (other): Lymph node in armpit swelled to golf ball size after last check-in, severe pain treated with switching 500mg naproxen/12hrs and 500mg/6 hrs and applying ice pack to reduce swelling, pain ranging from 4/10 to 8/10

2021-10-04

Systemic reaction (other): Lymph node still swollen and painful, treated with 500mg naproxen and ice pack

Release 10 — days 1–6 daily, dose 3

2021-10-05

Systemic reaction (other): Lymph node still swollen and tender to touch, pain less than previous days, no longer need pain medication to manage

2021-10-06

Systemic reaction (other): Breast/lymph node soreness present but mild

2021-10-07

Systemic reaction (other): Breast/lymph node pain is mild and does not interfere with ability to go to work or complete everyday activities

Release 10 — day 7, dose 3

2021-10-08

Systemic reaction (other): Lymph node swelling has improved, pain is mild and does not interfere with work or activities

Release 10 — day 35, dose 3

2021-11-07

Symptoms: Coughing a lot, negative COVID tests

Release 10 — 3 months, dose 3

2021-12-31

Symptoms: Increase in migraine frequency from 1-2/year to 1-2/month

Release 12 — 12 months, dose 3

2022-10-01

Symptoms: More frequent migraines

Release 12 — days 1–6 daily, dose 4

2022-11-06

Systemic reaction (other): Bacterial sinus infection being treated with antibiotics

2022-11-07

Systemic reaction (other): Being treated for a sinus infection with doxycycline

2022-11-08

Systemic reaction (other): Tested positive for covid

2022-11-09

Systemic reaction (other): Still recovering from Covid - PCR test confirmed

Release 12 — day 7, dose 4

2022-11-10

Systemic reaction (other): Covid symptoms, trouble breathing, coughing

Release 12 — day 28, dose 4

2022-12-01

Symptoms: Body aches with no fever - had Covid after vaccination

Release 12 — day 42, dose 4

2022-12-16

Symptoms: Influenza A and covid resurgence

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBreast tenderness · · ✓
SDChills ✓ ✓ ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDDiarrhoea ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHypersensitivity · · ✓
SDInfluenza · · ✓
SDIntermenstrual bleeding ✓ ✓ ✓
SDLymphadenopathy · · ✓
SDMenstrual disorder ✓ ✓ ✓
SDMigraine · · ✓
SDPain · · ✓
SDPalpitations · · ✓
SDPre-existing disease · · ✓
SDSARS-CoV-2 test negative · · ✓
SDVomiting ✓ ✓ ✓
SROBacterial infection · · ✓
SROBreast pain · · ✓
SROCough · · ✓
SROCOVID-19 · · ✓
SRODepression ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SRODyspnoea · · ✓
SROInsomnia ✓ ✓ ✓
SROLymph node pain · · ✓
SROLymphadenopathy · · ✓
SRONeuralgia · · ✓
SROPain · · ✓
SROParaesthesia · · ✓
SROSARS-CoV-2 test positive · · ✓
SROSelf-medication · · ✓
SROSinusitis · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release